Previous Close | 2.5700 |
Open | 2.6300 |
Bid | 2.4700 x 100 |
Ask | 2.5300 x 400 |
Day's Range | 2.5000 - 2.6300 |
52 Week Range | 1.9100 - 29.5600 |
Volume | |
Avg. Volume | 1,471,653 |
Market Cap | 92.957M |
Beta (5Y Monthly) | 0.39 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BioXcel Therapeutics ( NASDAQ:BTAI ) Full Year 2023 Results Key Financial Results Net loss: US$179.1m (loss widened by...
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2023 Earnings Call Transcript March 12, 2024 BioXcel Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.76, expectations were $-0.98. BioXcel Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […]
Q4 2023 BioXcel Therapeutics Inc Earnings Call